| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.53 | 0.05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |